Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 6.4710.2133.350.78-15.54

What is the latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS is 6.47 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar20246.47
Mar202310.21
Mar202233.35
Mar20210.78
Mar2020-15.54

How is Core EBITDA Growth of JENBURKT PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 6.47
-36.63
Mar2023 10.21
-69.39
Mar2022 33.35
4,175.64
Mar2021 0.78
Positive
Mar2020 -15.54 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹441.6 Cr 0.8% -4% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

0.8%

-4%

17.9%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses